References

Arora, Sankalp, Jayastu Senapati, Naveen Pemmaraju, et al. 2023. “Five-Year Follow up Results of Phase II Clinical Trial Evaluating Ruxolitinib (RUX) and Azacitidine (AZA) Combination Therapy in Patients (Pts) with Myelodysplastic Syndrome/Myeloproliferative Neoplasms (MDS/MPNs).” Blood 142 (Supplement 1): 1861–61. https://doi.org/10.1182/blood-2023-187035.

Knuth, Donald E. 1984. “Literate Programming.” Comput. J. (USA) 27 (2): 97–111. https://doi.org/10.1093/comjnl/27.2.97.